ENTITY
SK Bioscience

SK Bioscience (302440 KS)

232
Analysis
Health Care • South Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
bearish•MOG Digitech
•11 Jun 2023 06:50

Index Rebalance & ETF Flow Recap: HSCI, GDXJ, KRX New Deal, AMFI, Amman Mineral, Infratil

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
813 Views
Share
bullish•Douzone Bizon
•08 Jun 2023 08:11

KRX New Deal Index Rebalance Preview: A Change for Each Index

There is 1 change currently for each of the Secondary Battery, Bio, Internet & Game indices. There are some close contests among the top 3 stocks...

Logo
834 Views
Share
bearish•Posco Future M
•22 May 2023 07:03

Korea: What Are Foreign Investors Buying & Selling?

Foreign investors have been buying stock in Korea and hold 32% of the KOSPI market cap and 8.5% of the KOSDAQ market cap. There is a big dispersion...

Logo
731 Views
Share
bearish•Douzone Bizon
•04 May 2023 06:14

KRX New Deal Index Rebalance Preview: Potential & Close Changes in September

There were big moves on stocks that were changes at the March rebalance. We take a look at expected and close changes at the September rebalance....

Logo
859 Views
Share
bearish•Ecopro Co Ltd
•19 Apr 2023 01:39

Korean Holdcos Vs Opcos Gap Trading Opportunities in 2Q 2023

In this insight, we highlight the pricing gap divergences of the major Korean holdcos and opcos in 2Q 2023. We highlight 38 pair trades that...

Logo
600 Views
Share
x